Cargando…
Methodological Issues in the Clinical Validation of Biomarkers for Alzheimer’s Disease: The Paradigmatic Example of CSF
The use of biomarkers is profoundly transforming medical research and practice. Their adoption has triggered major advancements in the field of Alzheimer’s disease (AD) over the past years. For instance, the analysis of the cerebrospinal fluid (CSF) and neuroimaging changes indicative of neuronal lo...
Autores principales: | Canevelli, Marco, Bacigalupo, Ilaria, Gervasi, Giuseppe, Lacorte, Eleonora, Massari, Marco, Mayer, Flavia, Vanacore, Nicola, Cesari, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812267/ https://www.ncbi.nlm.nih.gov/pubmed/31680936 http://dx.doi.org/10.3389/fnagi.2019.00282 |
Ejemplares similares
-
Integrated care pathways on dementia in Italy: a survey testing the compliance with a national guidance
por: Gervasi, Giuseppe, et al.
Publicado: (2019) -
A National Survey of Centers for Cognitive Disorders and Dementias in Italy
por: Canevelli, Marco, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria
por: Bacigalupo, Ilaria, et al.
Publicado: (2018) -
Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021) -
An Estimate of Attributable Cases of Alzheimer Disease and Vascular Dementia due to Modifiable Risk Factors: The Impact of Primary Prevention in Europe and in Italy
por: Mayer, Flavia, et al.
Publicado: (2018)